G1 Therapeutics raises $50M to help lift sales for cancer drug


An oncology company in Research Triangle Park has raised new capital to support sales of its sole product and fund development of new cancer drugs.

Previous G1 Therapeutics raises $50M to support commercial, clinical plans
Next Downtown Seattle apartment development pad is back on the market